Grams of heavy money spent

According to the announcement of the China-Europe Fund, the two funds managed by Gelan have invested 679 million yuan in participating in the issuance of the leading innovative drug company, Beilitianheng. In addition, Zhu Shaoxing, deputy general manager of Fuguo Fund, and well-known fund manager Fan Yan, whose funds are also involved in the company's share issuance. From a financial perspective, in the recent adjustment trend of the innovative drug sector, a large amount of funds are actively entering the market through innovative drug-themed ETFs.